Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. - Wikidata - wikimedia - TriplyDB

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.

http://www.wikidata.org/entity/Q44258537

about

Simultaneous determination of ginkgolides A, B, C and bilobalide by LC-MS/MS and its application to a pharmacokinetic study in rats.Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract.Sesquiterpenoids lactones: benefits to plants and people.Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.Pharmacokinetic drug interactions involving Ginkgo biloba.Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.Urinary excretion of ginkgolide terpene lactones following acute consumption of Ginkgo biloba extract.In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.

P2860

Q35641471-9C426047-1185-429A-A469-8AE88AE26149 Q35854081-BDDC4972-E196-4E77-A08D-84A382454292 Q37007424-9C529746-6DE1-4FDC-85EC-875A9C1D5316 Q38109094-5FA9874F-0DBE-4C43-88A3-60FF67C51D4D Q38122439-172CB5BA-7BE4-4AEE-AA13-C27BD4EB4903 Q39018524-47256A4A-824B-4A81-90C7-2BD0490ACF9E Q44355737-1AAC7167-103B-448B-B3E9-DD6201B3845F Q46709627-9239197D-7764-4753-96D9-0376662286E5 Q49265078-D5678BBD-9C39-4435-9487-AAA63FFD9208

P2860

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.

http://www.wikidata.org/entity/Q44258537

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@en

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@nl

type

label

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@en

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@nl

prefLabel

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@en

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@nl

P1433

Q44258537-75D2C962-B94A-48B5-A299-E210D2B05547

P1476

Q44258537-00BCA9EF-6ABD-4145-AEB3-BC11D7B6956E

P2093

Q44258537-043ED298-96DC-4555-9B96-E0E73F422367

Q44258537-1AB0CFE1-E89E-42D9-A776-3833D6C9602F

Q44258537-1ACBAE97-4A55-46A2-A935-5C0BCA36CA87

Q44258537-1CE47EAB-50A6-48AC-9C87-3AEC96A37F26

Q44258537-5FE404DD-883E-4CEC-B6BA-88B1D3D43A70

Q44258537-E031E036-0906-43AA-8378-6FEFF4B467E2

P2860

Q44258537-02FEC1D3-1C04-4821-A4C2-66E6CC6B5EDF

Q44258537-04C132CE-4FB4-4D9E-92A7-867123114037

Q44258537-0AEF3A7F-92D8-4B76-A6F1-B0EB422E0398

Q44258537-16492A19-D3AC-402C-A0B3-B15A295EC94F

Q44258537-2D318650-DAA4-445A-B9A9-C6944D698798

Q44258537-3329EB0F-7851-4C59-AA6E-0A05D9FDAC59

Q44258537-337BDD4A-97A3-4BE8-AA8A-EA3078EE6F4E

Q44258537-35CCA62C-7117-444B-B100-2261C5D966B2

Q44258537-40745D69-A6F1-4799-88A7-516F0D32D627

Q44258537-81184787-C83F-4664-AC20-0B38593B5CF5

P304

Q44258537-B021344D-A8D7-4E07-B080-38A375A84B49

P31

Q44258537-B61044DF-65F2-439D-A2F2-05185C663550

P356

Q44258537-314830E4-D09F-48EE-9D13-A698520EEEE2

P433

Q44258537-E7C5F855-1811-40C7-AB5D-81F426411EFF

P478

Q44258537-B1E70E32-FCAF-46E5-8F0B-6A3671F9D68E

P577

Q44258537-D192198E-4A8B-4199-A5DD-DF89DB52DD84

P698

Q44258537-84C1651A-F17D-433F-91C3-0AEBBA9E72B4

P921

Q44258537-CF89E1AB-B60B-4FEE-9BE2-B52AB004AF0F

P356

P1433

Journal of Pharmacy and Pharmacology

P1476

Influence of pharmaceutical qu ...... om Ginkgo biloba preparations.

@en

P2093

A Biber

http://www.w3.org/2001/XMLSchema#string

B Schug

http://www.w3.org/2001/XMLSchema#string

H H Blume

http://www.w3.org/2001/XMLSchema#string

M Wonnemann

http://www.w3.org/2001/XMLSchema#string

S Kressmann

http://www.w3.org/2001/XMLSchema#string

W E Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms.

Ginkgo biloba for tinnitus: a review.

Mitochondrial oxidative stress plays a key role in aging and apoptosis.

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.

The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba.

ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain.

Age-related increase of oxidative stress-induced apoptosis in mice prevention by Ginkgo biloba extract (EGb761).

Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C.

Pharmaceutical quality of different Ginkgo biloba brands.

P304

1507-1514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1211/002235702199

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12495553

http://www.w3.org/2001/XMLSchema#string

P921